16 Healthcare Stocks Moving In Tuesday's Pre-Market Session

Gainers

  • Deciphera Pharmaceuticals, Inc. DCPH stock surged 123.1% to $44.50 during Tuesday's pre-market session. The market value of their outstanding shares is at $844.5 million. The most recent rating by Deutsche Bank, on July 18, is at Buy, with a price target of $42.00.
  • Cellect Biotechnology, Inc. APOP stock increased by 5.0% to $0.61. The market cap seems to be at $1.6 million.
  • Akers Biosciences, Inc. AKER shares surged 4.4% to $0.49. The market value of their outstanding shares is at $5.2 million.
  • Pfizer, Inc. PFE shares surged 4.2% to $36.87. The market value of their outstanding shares is at $205.4 billion. According to the most recent rating by Morgan Stanley, on July 30, the current rating is at Equal-Weight.
  • Vical, Inc. VICL shares moved upwards by 4.1% to $0.83. The market cap stands at $16.2 million.
  • Elanco Animal Health, Inc. ELAN shares surged 3.4% to $30.75. The market value of their outstanding shares is at $11.6 billion. According to the most recent rating by Guggenheim, on May 23, the current rating is at Neutral.
  • Bausch Health Companies, Inc. BHC stock moved upwards by 3.0% to $22.95. The most recent rating by H.C. Wainwright, on August 07, is at Buy, with a price target of $54.00.
  • Genmab, Inc. GMAB stock surged 2.5% to $19.62. The market cap stands at $11.9 billion. According to the most recent rating by Morgan Stanley, on August 12, the current rating is at Overweight.
  • CannTrust Holdings, Inc. CTST stock rose 2.4% to $2.35. The market cap stands at $320.7 million.
  • Histogenics, Inc. HSGX stock increased by 2.0% to $0.20. The market cap stands at $52.8 million.

 

Losers

  • Guardion Health Sciences, Inc. GHSI shares decreased by 41.2% to $0.35 during Tuesday's pre-market session. The market value of their outstanding shares is at $23.8 million.
  • Heat Biologics, Inc. HTBX shares fell 4.9% to $0.56. The market value of their outstanding shares is at $23.3 million. The most recent rating by Brookline Capital, on July 30, is at Buy, with a price target of $8.00.
  • Sienna Biopharmaceuticals, Inc. SNNA stock decreased by 4.0% to $0.96. The market value of their outstanding shares is at $346.5 million.
  • Clovis Oncology, Inc. CLVS stock plummeted 3.2% to $5.49. The most recent rating by Bank of America, on August 13, is at Neutral, with a price target of $7.00.
  • Cancer Genetics, Inc. CGIX shares fell 2.8% to $0.13. The market cap seems to be at $7.9 million.
  • Interpace Diagnostics Gr, Inc. IDXG stock plummeted 2.3% to $0.81. The market cap stands at $32.1 million.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsMovers & ShakersPre-Market OutlookMarketsMoversTrading IdeasGeneralHealthcare Stocks Pre-Market MoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!